Capricor Therapeutics
CAPR
#7633
Rank
NZ$0.80 B
Marketcap
NZ$13.87
Share price
0.80%
Change (1 day)
35.49%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -NZ$0.23 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.2 Billion a decrease over its 2024 earnings that were of -NZ$73.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.23 Billion17.29%
2025 -NZ$0.2 Billion159.57%
2024 -NZ$73.98 Million81.57%
2023 -NZ$40.75 Million-23.2%
2022 -NZ$53.05 Million44.93%
2021 -NZ$36.61 Million46.61%
2020 -NZ$24.97 Million78.71%
2019 -NZ$13.97 Million-49.7%
2018 -NZ$27.77 Million-724.78%
2017 NZ$4.44 M-112.93%
2016 -NZ$34.38 Million46.27%
2015 -NZ$23.51 Million106.82%
2014 -NZ$11.37 Million-48.41%
2013 -NZ$22.03 Million977.23%
2012 -NZ$2.05 Million-77.11%
2011 -NZ$8.94 Million-22.35%
2010 -NZ$11.51 Million-20.17%
2009 -NZ$14.42 Million-41.17%
2008 -NZ$24.5 Million41.05%
2007 -NZ$17.37 Million1098.87%
2006 -NZ$1.45 Million4101.55%
2005 -NZ$0.04 Million-0.97%
2004 -NZ$0.04 Million17.87%
2003 -NZ$0.03 Million3.66%
2002 -NZ$0.03 Million-30.11%
2001 -NZ$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.22 B-14,566.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.57 B-766.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.43 Billion 501.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.6 Billion 151.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$15.31 Million-93.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$30.2 Million-87.23%๐Ÿ‡บ๐Ÿ‡ธ USA